课题基金 / 基金详情

Hematopoeitic cell fates in the developing lung

Hematopoeitic cell fates in the developing lung
发育中的肺中的造血细胞命运
批准号:
7525953
负责人:
Alan Fine Fine
金额:
$40.63万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-20 至 2012-04-30

项目摘要

项目成果

Alan Fine Fine的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):在这项提案中,我们试图了解外源性CD45造血细胞在肺固有免疫系统发育和肺血管系统成熟中的作用。值得注意的是,我们的数据显示,胚胎肺包含两组解剖上不同的CD45细胞。一个CD45群体定位于间充质,含有早期和晚期巨噬细胞/髓系细胞。这一发现和数据显示,在暴露于内毒素的分离的胚胎肺培养中出现了成熟的巨噬细胞,这表明胚胎肺本身是髓系分化的场所。另一组CD45在胎儿期晚期(E18)最为明显,聚集在肺动脉分支周围。其中许多细胞共表达平滑肌肌动蛋白,呈扁平化,似乎处于结合到血管壁的不同阶段;进一步的研究表明,依赖Noch-3的信号控制着它们的命运。在这里,我们提出以下中心假设:一个胎儿CD45群体响应于间充质来源的信号而局部分化,以帮助建立肺的固有免疫系统,而第二个血管周围CD45群体直接促进肺动脉壁的成熟。在目标1中,我们将重点介绍CD45间充质部位。我们的研究将阐明髓系细胞成熟的个体发育,并鉴定产生刺激巨噬细胞和树突状细胞分化的信号的肺实质细胞。利用肺胚胎培养,我们将确定巨噬细胞和树突状细胞分化的准确区域,并评估肺上皮在这些事件中的作用。在目标2中,我们将重点关注血管周围的CD45细胞。我们将进一步定义它们的表型,评估它们在其他胚胎组织中的分布,并确定PU1依赖的髓系细胞分化对它们发育的重要性。在最后一组研究中,我们将重点研究Noch-3在决定细胞命运中的作用,并确定在该细胞群中起作用的功能相关的配体-Noch-3结合作用。通过这项工作,我们将阐明发育中的肺和造血系统之间的相互作用如何确保新生的肺为呼吸空气做好准备。项目简介:目前,很少或根本没有关于来自胎儿循环的细胞如何促进肺发育的信息。我们的研究表明,这些细胞不仅参与了肺免疫系统的建立,而且还参与了肺血管的发育。因此,这项工作将填补知识的主要空白,并应培养一种新的发展范式,以了解胚胎肺是如何配备呼吸空气的。阐明这些发育过程对于推进先天性肺部疾病以及困扰早产儿的特定肺部疾病的治疗至关重要。
英文摘要
DESCRIPTION (provided by applicant): In this proposal, we seek to understand the role of exogenously derived CD45+ hematopoeitic cells in the development of the lung's innate immune system, and in the maturation of the pulmonary vasculature. Notably, our data show that the embryonic lung contains 2 anatomically distinct sets of CD45+ cells. One CD45+ population localized to the mesenchyme, contains cells of early and late macrophage/myeloid lineage. This finding along with data showing that mature macrophages emerge in isolated embryonic lung cultures exposed to LPS, suggest that the embryonic lung itself is a site of myeloid differentiation. The other CD45+ population is most apparent in late fetal life (E18), aggregated around branches of the pulmonary artery. Many of these cells co-express smooth muscle actin, are flattened, and appear to be in various stages of incorporation into the vessel wall; further work suggests that notch-3 dependent signaling controls their fate. Herein, we propose the following central hypothesis: one fetal CD45+ population locally differentiates in response to mesenchyme-derived signals to help establish the lung's innate immune system, whereas the second peri-vascular CD45+ population directly contributes to maturation of the pulmonary artery wall. In Aim 1, we will focus on the CD45+ mesenchymal site. Our studies will clarify the ontogeny of myeloid cell maturation and identify lung parenchymal cells that produce signals stimulating macrophage and dendritic cell differentiation. Using lung embryonic cultures, we will then define the precise regions of macrophage and dendritic cell differentiation, and evaluate the role of the lung epithelium in these events. In Aim 2 we will focus on the peri-vascular CD45+ cells. We will further define their phenotype, evaluate their distribution in other embryonic tissues, and determine the importance of PU1 dependent myeloid cell differentiation for their development. In the final set of studies, we will focus on the role of notch-3 in cell fate determination and identify the functionally relevant ligand-notch-3 binding interaction that is operative in this cell population. Through this work, we will clarify how interactions between the developing lung and the hematopoeitic system ensure that the newly born lung is ready for air-breathing. PROJECT NARRATIVE: Currently, there is little or no information regarding how cells derived from the fetal circulation contribute to lung development. Our studies suggest that such cells are not only involved in establishment of the lung's immune system, but are also involved in development of the lung's blood vessels. This work will, thus, fill in major gaps in knowledge and should foster a new developmental paradigm for understanding how the embryonic lung becomes equipped air breathing. Elucidating these developmental processes is critical for advancing the treatment of congenital lung diseases, and the specific lung diseases that afflict premature infants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biology of Lymphangiogenesis in the Adult Lung
  • 批准号:
    10501003
  • 项目类别:
  • 资助金额:
    $56.95万
  • 财政年份:
    2022
  • 负责人:
    Alan Fine Fine
  • 依托单位:
Biology of Lymphangiogenesis in the Adult Lung
  • 批准号:
    10636911
  • 项目类别:
  • 资助金额:
    $59.59万
  • 财政年份:
    2022
  • 负责人:
    Alan Fine Fine
  • 依托单位:
MEDICAL STUDENT SUMMER RESEARCH PROGRAM IN HEART, LUNG AND BLOOD DISEASES (RPHLB)
  • 批准号:
    10597664
  • 项目类别:
  • 资助金额:
    $8.38万
  • 财政年份:
    2019
  • 负责人:
    Alan Fine Fine
  • 依托单位:
MEDICAL STUDENT SUMMER RESEARCH PROGRAM IN HEART, LUNG AND BLOOD DISEASES (RPHLB)
  • 批准号:
    10400064
  • 项目类别:
  • 资助金额:
    $10.12万
  • 财政年份:
    2019
  • 负责人:
    Alan Fine Fine
  • 依托单位:
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: